NFKB1 and diabetic kidney disease: These findings were consistent with previous studies exhibiting that myricetin attenuated inflammatory response in LPS-induced macrophages in vitro and in streptozotocin-induced diabetic nephropathy by inhibiting NF-κB signaling pathways (28, 37).